APRIL STUBBS: Open Payments
NPI 1124693387 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 19 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| Novo Nordisk Inc | 2 | $63 |
| Exact Sciences Corporation | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $17 |
Products named: Ozempic, VRAYLAR, Cologuard Collection Kit, SAPIEN 3 Ultra RESILIA, JARDIANCE, STRENSIQ, TMS NeuroHealth Centers Inc., GARDASIL 9.
Industry payments across SC — which companies pay providers there.
